EATG, News ViiV Healthcare launches phase III programme to evaluate a long-acting, injectable HIV treatment regimen November 18, 2016 1438
Facebook Twitter Google+ Post Views: 1,438 ARTHIV/AIDSTreatment Share the News Facebook Twitter VKontakte Google+ Fast-track update on investments needed in the AIDS responce. UNAIDS 2016. Reference. European Antibiotic Awareness Day 2016 Related News 2056 Behavioral intervention reduces HIV transmission risk in young transgender women 2548 Global progress towards hepatitis C elimination still blocked by cost of treatment, lack of diagnosis 2524 Vladimir Zhovtyak: European AIDS conference is a step forward to control the HIV/AIDS in Europe 2370 Patient Communities Agree on Shared Vision of HIV Treatment Regimen 2908 Glecaprevir/pibrentasvir is effective for people with HIV/HCV co-infection
2548 Global progress towards hepatitis C elimination still blocked by cost of treatment, lack of diagnosis
ПОИСК ПО САЙТУ 
поиск по ресурсному центру 
